News archive

January 2022

• • 19 January 2022
  • KBI Biopharma

  Selexis and Inotrem Enter Service Agreement to Advance Inotrem’s Chronic Inflammatory Disease Program

  Selexis and Inotrem have signed a service agreement to develop the cell line for Inotrem’s antibody-based candidate to address chronic inflammations

• • 18 January 2022
  • JSR Life Sciences

  Aqualung Therapeutics Corp., an Immunotherapeutics Biotech Company, Closes a $2.5M Convertible Note Raise With a Comm...

  Aqualung Therapeutics has closed a $2.5M convertible note fund raise led by a $1.5M investment from JSR Life Sciences, LLC

• • 12 January 2022
  • KBI Biopharma

  Hemogenyx Pharmaceuticals and Selexis SA Will Advance Hemogenyx’s Acute Myeloid Leukemia (AML) CDX Bispecific Antibod...

  Hemogenyx Pharmaceuticals will leverage Selexis’ SUREtechnology Platform™ of protein expression technologies and modular workflows

December 2021

• • 8 December 2021
  • Crown Bioscience

  Crown Bioscience Expands UK Facilities to Enable Growth of In Vivo Services

  Upgraded facility increases capacity for in vivo services by 30 percent and adds high frequency ultrasound capabilities to the company’s preclinical capabilities

• • 7 December 2021
  • Crown Bioscience

  Crown Bioscience Expands UK Facilities to Enable Growth of In Vivo Services

  Upgraded facility increases capacity for in vivo services by 30 percent and adds high frequency ultrasound capabilities to the Company’s preclinical capabilities

October 2021

• • 26 October 2021
  • Crown Bioscience

  Crown Bioscience Unveils New Identity

  The new brand reinforces the company’s commitment to the power of partnership and the infinite possibilities of scientific innovation

• • 11 October 2021
  • KBI Biopharma

  KBI Biopharma Completes Eurofins DiscoverX Products Specialized Bioassay Certification Program

  Companies will work together on critical components that can accelerate client-sponsored validation programs through downstream drug development

• • 7 October 2021
  • Crown Bioscience

  Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’ to Improve Response Predictability to Immuno-Oncology ...

  Platform combining phenotypic high content imaging analysis and three-dimensional models of fresh patient tumors to provide relevant analysis of drug responses that can inform candidate selection a...

• • 7 October 2021
  • Crown Bioscience

  Crown Bioscience Launches ‘3D Ex Vivo Patient Tissue Platform’ to Improve Response Predictability to Immuno-Oncology ...

  Platform combining phenotypic high content imaging analysis and three-dimensional models of fresh patient tumors to provide relevant analysis of drug responses that can inform candidate selection a...

September 2021

• • 30 September 2021
  • MBL

  MBL to Distribute Qkine’s Animal-free Growth Factors and Cytokines

  Medical & Biological Laboratories Co., Ltd. (MBL), a JSR Life Sciences Company, has signed a distributor agreement with Qkine Ltd. for sale of products in Japan.

• • 17 September 2021
  • MBL

  MBL establishes a new R&D and manufacturing site for in vitro diagnostic products and services in Shenzhen, China

  MBL, a JSR Life Sciences Company, announced that its subsidiary MBL Shenzhen Biotech Co., Ltd. has been established in full-scale operation as a new R&D and manufacturing site for in vitro diagnost...

August 2021

• • 30 August 2021
  • MBL

  MBL Launches New Automated Analyzer Kit to Quickly Detect Neutralizing Antibodies Against SARS-CoV-2

  Kit will help with understanding immune status of COVID-19 patients and promote research on vaccine efficacy